Researchers create novel drug that can prevent flu-induced l

Infection with the influenza virus leads to lung injury through inflammation over-activation that causes collateral damage to cells required for breathing.

Related Keywords

Gregory Cuny , Lawrence Fritz , Christian Loch , Anantha Duddupudi , Kathy Cai , Jessica Gaevert , Julius Beer , Peter Vogel , Stacey Schultz , Carly Deantoneo , Diego Rodriguez , Sameer Nikhar , Siddharth Balachandran , Ioannis Siokas , Mark Andrake , Riley Williams , Martin Schwemmle , Alexei Degterev , Bikash Thapa , Brandi Livingston , Seungheon Lee , Avishekh Gautam , David Boyd , Deutsche Forschungsgemeinschaft , Dingqiang Zhang , Paul Thomas , Maria Shubina , Daniel Schnepf , Raghavender Boda , Jude Children Research Hospital , National Institutes Of Health , Tufts University School Of Medicine , Jude Center , Influenza Research , University Of Freiburg , University Of Houston , Human Services , Fox Chase Cancer Center , Collaborative Influenza Vaccine Innovation Centers , Jude Department , Jude Children , Research Hospital , Tufts University School , Receptor Interacting Protein Kinase , Fox Chase Cancer , Ting Zhang , Chaoran Yin , Reaction Biology , Lee Ann Van De Velde , Victoria Meliopoulos , Jeremy Chase Crawford , Stacey Schultz Cherry , Douglas Green , National Institutes , Influenza Disease , Emergence Response , Flu , Inflammation , Poptosis , Breathing , Dancer , Fell , Children , Hospital , Immune System , Influenza , Medicine , Ouse Model , Necroptosis , Protein , Research , Virus ,